CLINICAL AND LABORATORY CHARACTERISTICS, DIAGNOSIS AND TREATMENT OF PYELONEPHRITIS IN CHILDREN DURING THE COVID-19 PANDEMIC

Many authors state that COVID-19 infection can complicate treatment and increase mortality, mainly in individuals with kidney disease . Purpose of work: study and treatment of clinical and laboratory features of pyelonephritis in children infected with COVID-19. Materials and methods of examination: Group I - children with pyelonephritis infected with COVID-19 - 50 children. Group II Comparison group consisted of children with pyelonephritis not infected with COVID-19 - 50 children. Results. Urinary syndrome was the leading clinical symptomcomplex. Laboratory examination in all children of the first group revealed massive leukocytosis, bacteriuria, leukocytosis with a left shift of the leukocytic formula, accelerated EHT and increased concentration of C-reactive protein. CONCLUSION: Our clinical observation shows that COVID-19, even in its mild form, causes exacerbation of pyelonephritis in children, while at the same time it is found that chronic pyelonephritis often relapses. In children with pyelonephritis against COVID-19, introduction of vitamin A into the standard treatment scheme 2, 3 days earlier allows normalization of membranolysis and cytolysis in the renal calyx system and parenchyma, and electron-transport function of the kidneys erythrocytes come to norm.

Перевод пока недоступен